Search Results 161-170 of 11336 for FSA eligible expenses 2026

  1. A Study To Evaluate The Safety And Effectiveness Of Pembrolizumab Compared To Placebo In Resected High-risk Stage II Melanoma Patients - Mayo Clinic

    The primary hypothesis of this study is that pembrolizumab increases recurrence-free survival (RFS) compared to placebo. Participation eligibility. Participant ...

  2. Postoperative Oral Tranexamic Acid in Patients Undergoing Primary Total Joint Arthroplasty - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender ... © 1998-2026 Mayo Foundation for Medical Education and Research (MFMER). All ...

  3. Medical Research & Education - Mayo Clinic News Network

    Julie Ferris-Tillman, Ph.D. February 11, 2026. Advancing epilepsy care: Mayo Clinic neurologist Dr.

  4. Medical Research & Education - Mayo Clinic News Network

    Julie Ferris-Tillman, Ph.D. February 11, 2026. Advancing epilepsy care: Mayo Clinic neurologist Dr. Gregory Worrell ...

  5. A Study To Test How Effective Belumosudil Tablets Are For Treating Adult Participants With Chronic Lung Allograft Dysfunction (ROCKaspire) - Mayo Clinic

    Male participants are eligible to participate if ... A female participant is eligible ... © 1998-2026 Mayo Foundation for Medical Education and Research (MFMER).

  6. Medical Research & Education - Mayo Clinic News Network

    Julie Ferris-Tillman, Ph.D. February 11, 2026. Advancing epilepsy care: Mayo Clinic neurologist Dr. Gregory Worrell ...

  7. Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma - Mayo Clinic

    Buparlisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Participation eligibility. Participant eligibility ...

  8. Stipend and Benefits - Nurse Practitioner or Physician Assistant Nephrology and Hypertension Fellowship (Arizona) - Mayo Clinic College of Medicine & Science

    This position is eligible ... Living expenses such as transportation, housing ... ©Opens in new tab 1998-2026 Mayo Foundation for Medical Education and Research.

  9. Bemarituzumab Plus Chemotherapy And Nivolumab Versus Chemotherapy And Nivolumab Alone - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. Medical Research & Education - Mayo Clinic News Network

    Latest stories ; Cancer · Brittany Cordeiro. August 3, 2026 ; Research · Rebecca Bromelkamp. August 3, 2026 ; Research · Alison Satake. July 29, 2026 ; Research.